Clinical Services > Respiratory

"We can't make the same mistake twice"

21 March, 2023 by Victoria Keays, Partner at Gordon Legal

A painful lung disease caused by inhaling harmful levels of silica dust, silicosis is costing Australian tradies their jobs and, ultimately, their lives.


Childhood LRTI linked to premature death: Lancet

10 March, 2023

Respiratory infections contracted during early childhood are associated with an increased risk of death from respiratory illness between 26 and 73 years of age.


"Crazy interesting": lung protein that could block COVID-19

10 February, 2023

A protein in the lung could form a natural protective barrier to SARS-CoV-2 in humans, as reported by University of Sydney scientists in PLOS Biology.


Virtual lung therapy delivered through a smartphone app

01 August, 2022

A browser-based smartphone app delivers therapy for people recovering from surgery and those with lung conditions involving overproduction of mucus.


Asthma preventer medicine overprescribed

01 August, 2022

Professor Helen Reddel and colleagues from the Woolcock Institute of Medical Research have written about finding the lowest effective dose to control asthma.


Some flu vaccine reactions could be misdiagnosed as anaphylaxis

04 July, 2022

Some adverse reactions to influenza vaccinations could be stress-related responses being misdiagnosed as anaphylaxis.


COPD management: trial to address deficiencies in primary care

13 May, 2022

A Cochrane Review has highlighted an urgent need to identify the best type of interventions to improve guideline-recommended management of COPD as well as patient-related outcomes in the primary care setting.


BOC O2matic PRO automated closed-loop oxygen therapy

23 August, 2021

The O2matic PRO from BOC is designed to quickly stabilise arterial oxygen saturation in patients suffering from conditions that can lead to respiratory distress.


Sydney-developed COVID-19 nasal spray seeks trial participants

22 July, 2021

ENA Respiratory is seeking 100 healthy Sydneysiders to participate in a phase I study of its anti-COVID-19 nasal spray.


Oxair addresses global oxygen supply shortage

01 April, 2021

In response to global shortages, Oxair is spreading the word about its off-the-shelf solution — Oxygen Pressure Swing Adsorption (PSA) systems.


National Asthma Council Australia urges asthmatics to get vaccinated

29 March, 2021

Updates to the Australian Asthma Handbook will help health professionals advise patients with asthma during the COVID-19 vaccine rollout.


Summing up health costs of the last bushfire season

01 October, 2020

Australian researchers have found that the 2019–2020 bushfire season racked up smoke-related health costs of around $1.95 billion.


Study reveals long COVID-19 recovery

12 August, 2020

University of Leeds researchers have identified a pattern of long-term symptoms experienced by people hospitalised with COVID-19.


In Conversation with Dr Harrison Steel

16 July, 2020

Dr Harrison Steel has been directly involved in two significant projects that have impacted the COVID-19 health crisis.


Preview released for updated Australian Asthma Handbook

15 June, 2020

The National Asthma Council Australia has released a preview of the updated Australian Asthma Handbook V2.1.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd